Corporate Venture Capital: Will It Remain A Mainstay If The Markets Improve?
This article was originally published in Start Up
Executive Summary
An analysis of corporate venture investment since the beginning of 2008.
You may also be interested in...
Financings Of The Fortnight: Corporate Venture Is Here To Stay
Private funding rounds involving corporate venture tend to be much richer in the biotech arena, a recent review indicates.
Financings Of The Fortnight: Corporate Venture Is Here To Stay
Private funding rounds involving corporate venture tend to be much richer in the biotech arena, a recent review indicates.
Abbott Ventures: Building A Venture Portfolio in Devices
Corporate venture investing has become an increasingly important source of capital as traditional venture firms remained squeezed. In devices, the latest entrant into the field is Abbott Ventures, which sees itself as an extension of Abbott's internal efforts to build its device pipeline, favoring mid-stage deals in technology and therapeutic areas that fit strategically with Abbott's existing device businesses.